Hormone replacement therapy is having a moment. Searches for "HRT" and "hormone replacement therapy perimenopause" have grown by over 1,271% in the past two years, according to Google Trends data. Celebrity advocacy, new research, and a cultural shift toward talking openly about menopause have all contributed. But with that surge of interest comes a surge of questions, confusion, and misinformation.
This guide is designed to give you clear, evidence-based information about HRT for perimenopause. Not scare tactics, not breathless enthusiasm, just the facts as the medical evidence stands in 2026.
Important disclaimer: This article is for informational purposes only. HRT is a medical treatment that requires a prescription and individualized assessment by a qualified healthcare provider. Nothing in this article should be taken as medical advice.
What Is HRT?
Hormone replacement therapy does exactly what the name suggests: it replaces the hormones your body is producing less of during perimenopause and menopause. The primary hormones involved are:
- Estrogen - the main hormone that declines during menopause, responsible for regulating hundreds of bodily functions including temperature regulation, bone density, cardiovascular health, brain function, skin elasticity, and vaginal health
- Progesterone - needed to protect the uterine lining from the effects of estrogen. If you still have your uterus, you need progesterone alongside estrogen
- Testosterone - sometimes added for libido, energy, and cognitive function, though this is less commonly prescribed and not approved for women in all countries
HRT replaces these hormones at levels designed to alleviate symptoms and provide protective health benefits. It does not return your body to premenopausal hormone levels. The goal is symptom relief and health protection at the lowest effective dose.
Types of HRT
Understanding the different types helps you have an informed conversation with your doctor.
Combined HRT (Estrogen + Progesterone)
If you have a uterus, you need both estrogen and progesterone. Taking estrogen alone can cause the uterine lining to thicken, increasing the risk of endometrial cancer. Progesterone protects against this.
Combined HRT comes in two patterns:
- Sequential (cyclical): Estrogen taken continuously, progesterone added for 12 to 14 days per cycle. This typically produces a regular withdrawal bleed. Usually recommended for women in perimenopause or early menopause.
- Continuous combined: Both hormones taken every day. No regular bleeds (though spotting can occur initially). Usually recommended for women who are at least 12 months past their last period.
Estrogen-Only HRT
If you have had a hysterectomy (uterus removed), you only need estrogen. This simplifies the regimen and avoids the need for progesterone.
Body-Identical vs. Synthetic
This is an important distinction that generates a lot of confusion:
- Body-identical (micronized) hormones: These are manufactured to be molecularly identical to the hormones your body produces naturally. The most common are 17-beta estradiol (estrogen) and micronized progesterone (often sold as Utrogestan or Prometrium). They are produced in regulated pharmaceutical facilities and are available on prescription. The British Menopause Society and most current guidelines prefer body-identical hormones.
- Synthetic hormones: These are not molecularly identical to human hormones. They include conjugated equine estrogens (derived from pregnant horse urine, brand name Premarin) and synthetic progestins (like medroxyprogesterone acetate). These were the hormones used in the 2002 WHI study that caused widespread fear about HRT.
- "Bioidentical" compounded hormones: These are custom-mixed by compounding pharmacies. While they may use body-identical molecules, they are not regulated to the same standards as pharmaceutical products. Doses may be inconsistent, and claims about their superiority are not supported by evidence. The Endocrine Society and ACOG recommend regulated body-identical hormones over compounded products.
Delivery Methods
How you take HRT matters. Different delivery methods have different risk profiles:
- Transdermal (patches, gels, sprays): Estrogen is absorbed through the skin, bypassing the liver. This is the preferred delivery method according to current guidelines because it carries a lower risk of blood clots compared to oral estrogen. Patches are applied once or twice weekly. Gels and sprays are applied daily.
- Oral (pills/tablets): Convenient but passes through the liver first, which increases the production of clotting factors. The blood clot risk, though still small, is higher with oral estrogen. Oral micronized progesterone is commonly prescribed alongside transdermal estrogen.
- Vaginal (pessaries, rings, creams): Low-dose local estrogen for urogenital symptoms (vaginal dryness, urinary symptoms). Acts locally with minimal systemic absorption. Can be used alongside systemic HRT or on its own for localized symptoms. The NICE guidelines note that vaginal estrogen can be used long-term and does not carry the same risks as systemic HRT.
What HRT Can Help With
HRT is the most effective treatment available for the majority of menopause symptoms. According to the North American Menopause Society (NAMS), here is what HRT can address:
Vasomotor Symptoms
Hot flashes and night sweats are the most common reason women start HRT, and it is remarkably effective. Studies consistently show a 75 to 90% reduction in hot flash frequency and severity. Most women notice improvement within 2 to 4 weeks.
Sleep
By reducing night sweats and through direct effects on sleep architecture, HRT often significantly improves sleep quality. A study in the Journal of Clinical Endocrinology and Metabolism found that HRT improved both objective sleep measures and subjective sleep quality.
Mood and Psychological Symptoms
Estrogen interacts with serotonin, dopamine, and norepinephrine, all neurotransmitters involved in mood regulation. HRT, particularly transdermal estradiol, has been shown to improve perimenopausal depression and anxiety in multiple studies. A 2019 study published in JAMA Psychiatry found that transdermal estradiol was effective for preventing depressive episodes during perimenopause.
Cognitive Function
Brain fog is one of the most distressing perimenopause symptoms. While long-term cognitive outcomes are still being studied, research from the Women's Health Initiative Memory Study and other trials suggests that HRT started during perimenopause or early menopause may support cognitive function. The key appears to be timing: starting within the "window of opportunity" (see below).
Joint Pain
Many women are surprised to learn that HRT can help with joint pain. Estrogen has anti-inflammatory properties and supports joint health. A large observational study found that women on HRT reported significantly less joint pain compared to non-users.
Bone Health
This is one of the best-established benefits. HRT prevents and can partially reverse the rapid bone loss that occurs during the menopause transition. The International Osteoporosis Foundation recognizes HRT as a first-line treatment for osteoporosis prevention in menopausal women.
Cardiovascular Health
When started within 10 years of menopause onset or before age 60, HRT appears to be cardioprotective. This is known as the "timing hypothesis," and it has been supported by multiple analyses. A 2015 Cochrane review found that women who started HRT early had a significant reduction in cardiovascular events and mortality.
The Safety Question
No discussion of HRT is complete without addressing the 2002 Women's Health Initiative (WHI) study, which fundamentally changed the conversation about hormone therapy for over two decades.
What the WHI Actually Found
The WHI was a large randomized controlled trial that tested combined HRT (oral conjugated equine estrogen plus synthetic medroxyprogesterone acetate) in women aged 50 to 79. In 2002, the combined HRT arm was stopped early because of a small increased risk of breast cancer, blood clots, and stroke.
The headlines were alarming. Women and doctors panicked. HRT prescriptions plummeted by over 70% worldwide. Millions of women stopped treatment or never started.
What the Headlines Missed
Over the past two decades, extensive reanalysis of the WHI data and subsequent studies have revealed critical nuances:
The participants were older than typical HRT users. The average age was 63. Many were more than 10 years past menopause. The study was not designed to test HRT in perimenopause or early menopause, which is when most women start.
The hormones used were synthetic, not body-identical. The WHI used conjugated equine estrogens (Premarin) and medroxyprogesterone acetate (Provera). Current guidelines prefer body-identical 17-beta estradiol and micronized progesterone, which have different risk profiles.
Oral estrogen carries higher clot risk than transdermal. The WHI used oral estrogen only. Transdermal estrogen (patches, gels) does not carry the same clot risk because it bypasses the liver.
The absolute risk increases were small. The WHI found an additional 8 breast cancer cases per 10,000 women per year in the combined HRT group. For context, obesity increases breast cancer risk more than HRT at these doses. And the estrogen-only arm actually showed a decreased breast cancer risk.
The estrogen-only arm showed benefits. Women who had hysterectomies and took estrogen alone had lower rates of breast cancer, fewer fractures, and a trend toward lower mortality.
Current Medical Consensus
Major medical organizations have updated their positions based on the totality of evidence:
The North American Menopause Society, the British Menopause Society, the International Menopause Society, and the Endocrine Society all agree on the following:
- For symptomatic women under 60, or within 10 years of menopause, the benefits of HRT generally outweigh the risks
- Transdermal estrogen is preferred over oral for its lower clot risk
- Body-identical hormones (estradiol + micronized progesterone) are preferred
- Treatment should be individualized based on symptoms, risk factors, and preferences
- There is no arbitrary time limit for HRT use; duration should be reviewed regularly
The FDA removed its black box warning on hormone therapy products, reflecting the evolved understanding of benefits and risks.
Who Should NOT Take HRT
Despite the positive reassessment, HRT is not appropriate for everyone. Current guidelines advise against HRT or require specialist evaluation in the following cases:
- Current or recent history of breast cancer (particularly hormone-receptor-positive)
- History of blood clots (deep vein thrombosis or pulmonary embolism), though transdermal estrogen may be considered with specialist input
- Active liver disease
- Unexplained vaginal bleeding (must be investigated first)
- History of stroke
- Known clotting disorders (e.g., Factor V Leiden), though transdermal routes may be safer
If any of these apply to you, discuss your options with a menopause specialist. There are non-hormonal alternatives for many symptoms.
Starting HRT: What to Expect
If you and your doctor decide HRT is right for you, here is what the first few months typically look like:
Weeks 1 to 2: Some women feel improvement quickly, particularly in hot flashes and sleep. Others take longer.
Weeks 2 to 6: Adjustment period. Common initial side effects include breast tenderness, bloating, headaches, nausea (more common with oral), and mood fluctuations. These typically settle within 4 to 8 weeks. Your body is adjusting to the new hormone levels.
Months 2 to 3: Most women see significant symptom improvement by this point. If you have not, your dose or formulation may need adjustment. This is where tracking your symptoms becomes invaluable.
Month 3 and beyond: Follow-up with your doctor to assess response and adjust if needed. Some women need dose changes, a switch from sequential to continuous combined, or the addition of testosterone for persistent low libido or fatigue.
Why Tracking Matters for HRT
This is where a symptom tracker becomes genuinely medical-grade useful.
When you start HRT, you are establishing a new baseline. Your doctor needs to know: Which symptoms improved? Which did not? Did new symptoms appear? How quickly did changes happen?
Without data, your follow-up appointment becomes a vague conversation: "I think I feel better, maybe?" With tracked data, it becomes precise: "Hot flashes dropped from 8 per day to 2 in the first month. Sleep improved from an average of 4 hours to 6.5. But my mood has not improved and I have had new headaches."
That level of detail helps your doctor make better decisions about dose adjustments, formulation changes, or additional interventions.
Tracking is also essential if you ever decide to stop HRT. Gradual dose reduction with symptom monitoring helps ensure a smoother transition than abrupt discontinuation.
Alternatives to HRT
Not everyone can or wants to take HRT. Here are evidence-based alternatives for specific symptoms:
For hot flashes: Low-dose SSRIs or SNRIs (paroxetine, venlafaxine) have been shown to reduce hot flashes by 40 to 60%. These are the primary non-hormonal pharmaceutical option. Gabapentin is another option, particularly if hot flashes are worst at night. Oxybutynin, a medication originally for overactive bladder, has also shown effectiveness in clinical trials.
For mood and anxiety: SSRIs and SNRIs can help, particularly if mood symptoms are primary. Cognitive behavioral therapy (CBT) has strong evidence for managing both mood and hot flashes during menopause. Regular exercise has consistent evidence for improving mood.
For sleep: CBT for insomnia (CBT-i) is the first-line treatment for insomnia regardless of cause. Melatonin may help with sleep onset. Good sleep hygiene practices are foundational.
For vaginal and urogenital symptoms: Vaginal estrogen (not systemic) is effective, low-risk, and can be used even by many women who cannot take systemic HRT. Vaginal moisturizers and lubricants provide symptom relief.
For bone health: Weight-bearing exercise, adequate calcium and vitamin D, and medications like bisphosphonates if bone density is low.
Supplements: Some women find relief with supplements like black cohosh (for hot flashes), magnesium (for sleep and mood), and ashwagandha (for stress and anxiety). See our guide on the best supplements for perimenopause for detailed evidence on each.
Lifestyle: Regular exercise, stress management, balanced nutrition, and adequate sleep form the foundation. These are not replacements for HRT when symptoms are severe, but they support overall wellbeing and can amplify the benefits of any treatment.
The Bigger Picture
HRT is not a cure-all. It is a powerful tool that works best when it is part of a broader approach to navigating the menopause transition. That approach includes understanding what is happening to your body, tracking your symptoms so you have data to act on, building a relationship with a knowledgeable healthcare provider, making lifestyle adjustments that support your changing body, and connecting with other women going through the same experience.
The decades of fear that followed the 2002 WHI study deprived millions of women of effective treatment. The pendulum is now swinging back, supported by better evidence and more nuanced understanding. But the decision to start HRT is still deeply personal. It should be made with your doctor, based on your specific symptoms, your specific risk factors, and your specific goals.
You deserve to make that decision with accurate information, not outdated fear.
Start Tracking Your Symptoms
Whether you are considering HRT, already taking it, or exploring alternatives, tracking your symptoms gives you the data you need to make informed decisions and have productive conversations with your healthcare provider.